Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Toronto
$120,000.00
Development Of A Novel, Scalable, Neurobiologically-Guided Transcranial Magnetic Stimulation Protocol For The Treatment Of Cannabis Use Disorder
EF 2024-25
Résumé
Cannabis use has been increasing in recent years, largely due to legalization. Unfortunately, this rise in use has also led to more cases of cannabis use disorder (CUD), affecting about 3% of users. CUD is associated with a lower quality of life and worsening of other mental health issues. Unfortunately, current treatment options are limited and not effective, creating an urgent need for new approaches. One potential approach is repetitive transcranial magnetic stimulation (rTMS), a non-invasive method that uses magnetic pulses to stimulate specific areas of the brain, gradually changing brain activity in those regions. rTMS has shown promise in treating other addictions by targeting brain circuits involved in craving and substance use, but its effectiveness for cannabis addiction is underexplored. This clinical trial will test whether a 4-week course of rTMS is a practical and tolerable treatment for CUD. Participants will be randomly assigned to receive either low- or high-frequency rTMS sessions once a day, 5 days a week, for 4 weeks. The treatment will target brain areas-the prefrontal cortex and insula-that are involved in cannabis use disorder. During the trial, participants' cannabis use (consumption, craving, withdrawal) and psychiatric symptoms (depression and anxiety) will be measured through weekly check-ins and urine tests. Cognitive performance will also be assessed, and participants may opt for brain scans before and after treatment. This study aims to establish a new brain-based treatment for CUD, offering a solution where few effective options exist today. By evaluating substance-use, psychiatric, cognitive, and neuroimaging effects, the results may offer novel insights into the management of cannabis addiction, potentially improving outcomes for those struggling with this disorder.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
518332
Name
Mehta Dhvani
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Doctoral Research Awards - A
Projecttitle
Development Of A Novel, Scalable, Neurobiologically-Guided Transcranial Magnetic Stimulation Protocol For The Treatment Of Cannabis Use Disorder
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Brain Stimulation; Cannabis Use Disorder; Cognition; Craving; Functional Magnetic Resonance Imaging; Neuroimaging; Neuromodulation; Repetitive Transcranial Magnetic Stimulation; Substance Use Disorder
Abstract
Cannabis use has been increasing in recent years, largely due to legalization. Unfortunately, this rise in use has also led to more cases of cannabis use disorder (CUD), affecting about 3% of users. CUD is associated with a lower quality of life and worsening of other mental health issues. Unfortunately, current treatment options are limited and not effective, creating an urgent need for new approaches. One potential approach is repetitive transcranial magnetic stimulation (rTMS), a non-invasive method that uses magnetic pulses to stimulate specific areas of the brain, gradually changing brain activity in those regions. rTMS has shown promise in treating other addictions by targeting brain circuits involved in craving and substance use, but its effectiveness for cannabis addiction is underexplored. This clinical trial will test whether a 4-week course of rTMS is a practical and tolerable treatment for CUD. Participants will be randomly assigned to receive either low- or high-frequency rTMS sessions once a day, 5 days a week, for 4 weeks. The treatment will target brain areas-the prefrontal cortex and insula-that are involved in cannabis use disorder. During the trial, participants' cannabis use (consumption, craving, withdrawal) and psychiatric symptoms (depression and anxiety) will be measured through weekly check-ins and urine tests. Cognitive performance will also be assessed, and participants may opt for brain scans before and after treatment. This study aims to establish a new brain-based treatment for CUD, offering a solution where few effective options exist today. By evaluating substance-use, psychiatric, cognitive, and neuroimaging effects, the results may offer novel insights into the management of cannabis addiction, potentially improving outcomes for those struggling with this disorder.
Competitiondate
202411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Mehta, Dhvani
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~